# VIVAKOR, INC. (VIVK) · Edgar & Edgarette company card

> Vivakor (VIVK) grew revenue 16.3% in FY2025 to $104 million, operating margin -61.1% against a 3.5% median for refuse systems, equity 36.4% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1450704 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/VIVK) · [JSON](https://www.pops4.com/boards/company/VIVK.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $104M |
| Revenue growth, 1 year | 16.3% |
| Revenue growth per year | 213.0% |
| Operating margin | -61.1% (prior year -24.5%) |
| Net margin | -105.6% |
| Operating cash flow | −$16M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $265,019 |
| Long-term debt | — |
| Total assets | $113M |
| Total equity | $41M |
| Equity ÷ assets | 36.4% |
| Return on equity | -266.8% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Piotroski F: 5 of 9 (middling)
- Beneish M: -6.35 (below the −1.78 line)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed late annual report notice, late quarterly report notice in the last 12 months; operating cash flow was negative; operating loss: a margin of -61.1% in FY2025; revenue is hard to predict: its 80% range is ±32%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $104.4M (FY2025). Experience: revenue up 16.3% on the year, up 213.0% a year over 4 years; operating margin -61.1%, down from -24.5%. Soundness: equity 36.4% of assets, return on equity -266.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $99.5M and $194.8M next year (method v4.1: its own 3-year record of growth weighed at 40% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $84.0M to $232.5M. A statistical range, not company guidance. Against peers (9 filers, $50M+ revenue, its industry group): operating margin -61.1% against a 3.5% median; growth 16.3% against 4.3%.

Range logged 2026-10-01, receipt 0e5552171ede034f, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item NT 10-K Late annual report notice: 1, latest 2026-03-31 ([filing](https://www.sec.gov/Archives/edgar/data/1450704/000182912626002909/0001829126-26-002909-index.htm))
- Item 3.01 Exchange listing notice or transfer: 3, latest 2026-04-28 ([filing](https://www.sec.gov/Archives/edgar/data/1450704/000182912626004048/0001829126-26-004048-index.htm))
- Item NT 10-Q Late quarterly report notice: 2, latest 2026-08-14 ([filing](https://www.sec.gov/Archives/edgar/data/1450704/000182912626008899/0001829126-26-008899-index.htm))
- Item 5.02 Director or officer change: 1, latest 2026-09-30 ([filing](https://www.sec.gov/Archives/edgar/data/1450704/000182912626010624/0001829126-26-010624-index.htm))

## Recent filings

- 8-K · filed 2026-11-10 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1450704/000182912626012212/0001829126-26-012212-index.htm)
- 8-K · filed 2026-11-04 · 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1450704/000182912626011979/0001829126-26-011979-index.htm)
- 8-K · filed 2026-10-15 · 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1450704/000182912626011193/0001829126-26-011193-index.htm)
- 8-K · filed 2026-10-09 · 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1450704/000182912626010995/0001829126-26-010995-index.htm)
- 8-K · filed 2026-10-06 · 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1450704/000182912626010815/0001829126-26-010815-index.htm)
- 8-K · filed 2026-09-30 · 1.01 Entry into a Material Definitive Agreement; 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1450704/000182912626010624/0001829126-26-010624-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001450704.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1450704

## Cite

POPS4, Edgar & Edgarette: VIVAKOR, INC. (VIVK) company card, from the company's own SEC filings, accessed 2026-11-16, https://www.pops4.com/boards/company/VIVK. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

